Antiarrhythmic Drug Management

  • Henry H. Hsia

Abstract

This chapter focuses on the electrophysiologic principles of antiarrhythmic drug treatment of supraventricular and ventricular arrhythmias in critically ill patients. Here we do not present a comprehensive review of individual antiarrhythmic agents but instead provide a framework for clinical approaches to antiarrhythmic drug selection based on the mechanisms of the target arrhythmia. Antiarrhythmic drugs are agents that exert their effects either directly or indirectly on cellular impulse generation or conduction. They alter cellular membrane potential by interactions with membrane receptors or ionic channels. This chapter presents an overview of antiarrhythmic drug management, including (1) a review of cellular electrophysiology, (2) a general classification of antiarrhythmic drugs, (3) a survey of arrhythmia mechanisms, and (4) clinical correlation of antiarrhythmic drug effects on the heart.

Keywords

Antiarrhythmic Drug Refractory Period Action Potential Duration Structural Heart Disease Plasma Drug Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Anonymous. The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831–1851.CrossRefGoogle Scholar
  2. ESVEM Investigators. The ESVEM Trial: electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. Circulation 1989; 76 (6): 1354–1360.Google Scholar
  3. Hillis LD, Lange RA, Wells PJ, Winniford MD. Manual of Clinical Problems in Cardiology. Boston: Little, Brown, 1992.Google Scholar
  4. Hsia HH. Work-up and management of patients with sustained and non-sustained monomorphic ventricular tachycardias. Cardiol Clin 1993; 11: 21–37.PubMedGoogle Scholar
  5. Opie L. The Heart: Physiology, Metabolism, Pharmacology, Therapy. New York: Grune Stratton, 1987.Google Scholar
  6. Podrid PJ, Kowey PR (eds) Handbook of Cardiac Arrhythmia. Baltimore: Williams Wilkins, 1996.Google Scholar
  7. Pratt CM. The inversed relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio. Am Heart J 1989; 118: 433–440.PubMedCrossRefGoogle Scholar
  8. Reiser HJ, Horowitz LN (eds) Mechanism and Treatment of Cardiac Arrhythmias: Relevance of Basic Studies to Clinical Management. Munich: Urban Schwarzenberg, 1985.Google Scholar
  9. Stambler BS. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94: 1613–1621.PubMedCrossRefGoogle Scholar
  10. Zipes DP, Jalife J (eds) Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Saunders, 1996.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Henry H. Hsia

There are no affiliations available

Personalised recommendations